GSK vs PAYX · P/E 13, $103.31B cap vs P/E 22, rev $6.51B
GlaxoSmithKline PLC ADR (GSK) versus Paychex Inc (PAYX) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Paychex Inc (PAYX) is a software - application company listed on NASDAQ.
GSK does not have a complete income-statement cache yet.
Latest reported PAYX revenue for 2026-05-31 was $6.51B. Net income was $1.76B. Revenue was up 16.9% from 2025-05-31 to 2026-05-31. PAYX currently screens at market cap $34.96B and trailing P/E 21.5.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. PAYX currently screens at market cap $34.96B and trailing P/E 21.5.
Not investment advice. Open the GSK and PAYX stock pages for the full models.
Not investment advice.